Drug Shortage Report for SODIUM CHLORIDE INJECTION, USP
Report ID | 170965 |
Drug Identification Number | 02139510 |
Brand name | SODIUM CHLORIDE INJECTION, USP |
Common or Proper name | SODIUM CHLORIDE INJECTION, USP |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM CHLORIDE |
Strength(s) | 234MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 100mL |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2022-10-04 |
Actual start date | 2022-10-04 |
Estimated end date | 2023-02-01 |
Actual end date | 2023-01-31 |
Shortage status | Resolved |
Updated date | 2023-02-09 |
Company comments | Effective January 1, 2023, allocations for our Sodium Chloride Injection, USP 4 mmol/mL PBP Vial 100 mL will be increased to cover the 200 mL backorder. Contract customers will be allocated 100% of historical 100 mL demand plus 100% of historical 200 mL demand at a 2:1 ratio (2 vial of 100 mL = 1 vial of 200 mL), and 100% of historical 30 mL demand at a 1:2 ratio (1 vial of 100 mL = 2 vials of 30 mL). |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2023-02-09 | French | Compare |
v8 | 2023-02-09 | English | Compare |
v7 | 2023-01-02 | French | Compare |
v6 | 2023-01-02 | English | Compare |
v5 | 2022-12-05 | French | Compare |
v4 | 2022-12-05 | English | Compare |
v3 | 2022-10-05 | English | Compare |
v2 | 2022-10-03 | French | Compare |
v1 | 2022-10-03 | English | Compare |
Showing 1 to 9 of 9